Literature DB >> 2746716

Methadone maintenance program for AIDS-affected opiate addicts.

J L Sorensen1, S L Batki, P Good, K Wilkinson.   

Abstract

To slow the spread of AIDS, it may be important for substance abuse treatment programs to give priority admission to patients who are HIV-infected and infectious. A new program is described that provides methadone maintenance treatment to opiate addicts who are "AIDS affected"--heroin addicts diagnosed with AIDS, AIDS-related complex (ARC), or other significant symptoms of HIV infection. The program aims to protect the health of patients and to protect the general public by slowing the spread of the human immunodeficiency virus (HIV). This article describes the program's history and goals, its referral and patient admission process, methods of assessment and treatment planning, medical care, counseling procedures, tolerance for misbehavior, philosophy toward eventual detoxification, and procedures that maintain confidentiality.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2746716     DOI: 10.1016/0740-5472(89)90035-4

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  4 in total

Review 1.  Methadone maintenance in the treatment of opioid dependence. A current perspective.

Authors:  J E Zweben; J T Payte
Journal:  West J Med       Date:  1990-05

Review 2.  Drug abuse, psychiatric disorders, and AIDS. Dual and triple diagnosis.

Authors:  S L Batki
Journal:  West J Med       Date:  1990-05

3.  Utilization of on-site primary care services by HIV-seropositive and seronegative drug users in a methadone maintenance program.

Authors:  P A Selwyn; N S Budner; W C Wasserman; P S Arno
Journal:  Public Health Rep       Date:  1993 Jul-Aug       Impact factor: 2.792

4.  Directly administered antiretroviral therapy: pilot study of a structural intervention in methadone maintenance.

Authors:  James L Sorensen; Nancy A Haug; Sandra Larios; Valerie A Gruber; Jacqueline Tulsky; Elisabeth Powelson; Deborah P Logan; Bradley Shapiro
Journal:  J Subst Abuse Treat       Date:  2012-09-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.